Table 5.
Parameters | Person Months | Number of Events | Incidence Rates * | Median (Range) of Follow Up Time |
---|---|---|---|---|
Overall | 7434.35 | 100 | 13.45 | 45.42 (0.23–85.81) |
Serum total SOD activity < median | 2847.94 | 42 | 14.75 | 36.30 (0.39–85.81) |
Serum total SOD activity > median | 3080.32 | 44 | 14.28 | 46.52 (0.23–80.52) |
Serum SOD1 concentration < median | 3842.83 | 38 | 9.89 | 47.51 (1.94–78.35) |
Serum SOD1 concentration > median | 3586.13 | 61 | 17.01 | 28.50 (0.23–85.81) |
Serum SOD2 concentration < median | 3052.47 | 37 | 12.12 | 48.13 (2.04–79.40) |
Serum SOD2 concentration > median | 3129.96 | 49 | 15.66 | 33.60 (0.23–85.81) |
SOD: superoxide dismutase; SOD1: superoxide dismutase 1; SOD2: superoxide dismutase 2; *: per 1000 person months; event (endpoint) was defined as all-cause mortality in lung cancer patients.